Skip to content

Form 4 filed by Kelly Thomas Patrick

Kelly Thomas Patrick filed this Form 4 on XENE (Xenon Pharmaceuticals Inc.) with 2 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-17 00:22:19 UTC.

Accession
0001193125-26-424428
Filed
2026-10-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: XENE · Xenon Pharmaceuticals Inc. (CIK 1582313)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Shares 2026-10-15M exercised+7,50022,500D
Restricted Share Units derivative2026-10-15M exercised-7,500$022,500D